Guangzhou Virotech Pharmaceutical Co., Ltd.

This early-phase study tests a virus called VRT106 that is designed to infect and destroy cancer cells. About 30 adults with advanced solid tumors that haven't responded to standard treatments will receive injections directly into their tumors. The main goals are to check safety …

This study tests a new drug, VRT106, in 42 adults with glioblastoma that has come back or worsened. The goal is to see if it is safe and can shrink tumors or help people live longer. Participants receive the drug by injection, and doctors monitor side effects and how well it work…